The Good Gut Anti-Inflammatory Diet

At last, a book that shows you how to reverse the negative effects of inflammation, so you look and feel younger and live longer, happier and healthier. For over four decades, world-leading independent medical research organisation the Centenary Institute has been producing breakthroughs in our biggest health challenges. Out of their mission to make people's lives better comes The Good Gut Anti-Inflammatory Diet. • Understand inflammation, a fundamental cause of many life-altering diseases, and the various factors causing it • Learn how balancing your gut with the right food choices can help manage inflammation and change your life • Enjoy 50 versatile, delicious recipes from Aussie author and chef Fast Ed Halmagyi • Benefit from nutrition tips and recipes from Dr Clare Bailey Refocus on your health and energy, prevent sickness and reset yourself one delicious meal at a time.

Professor Phil Hansbro is an internationally recognised research leader in the study of respiratory diseases, such as asthma, chronic obstructive airway disease (COPD, aka emphysema), idiopathic pulmonary fibrosis (IPF), and infections and is developing interests in lung cancer. His work is substantially contributing to understanding the pathogenesis and developing new therapies for these diseases. His work has made internationally important contributions and led to the identification of novel avenues for therapy that are under further study. This is achieved through the development of novel mouse models that recapitulate the hallmark features of human disease, including infections, asthma, COPD, IPF and now lung cancer. He employs these models in integrated approaches (infection, immunity and physiology with particular expertise in lung function analysis) to understand human diseases, and develop new treatment strategies. Research outcomes have a translational goal and his studies are conducted in parallel with collaborative human studies with clinical researchers.

Auteur

Professor Phil Hansbro is an internationally recognised research leader in the study of respiratory diseases, such as asthma, chronic obstructive airway disease (COPD, aka emphysema), idiopathic pulmonary fibrosis (IPF), and infections and is developing interests in lung cancer. His work is substantially contributing to understanding the pathogenesis and developing new therapies for these diseases.

His work has made internationally important contributions and led to the identification of novel avenues for therapy that are under further study. This is achieved through the development of novel mouse models that recapitulate the hallmark features of human disease, including infections, asthma, COPD, IPF and now lung cancer. He employs these models in integrated approaches (infection, immunity and physiology with particular expertise in lung function analysis) to understand human diseases, and develop new treatment strategies. Research outcomes have a translational goal and his studies are conducted in parallel with collaborative human studies with clinical researchers.